http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106932579-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-085 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57438 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 |
filingDate | 2017-03-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2018-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2018-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-106932579-B |
titleOfInvention | A kind of kit of the liver cancer detection based on liquid biopsy |
abstract | The kit for the liver cancer detection based on liquid biopsy that the present invention provides a kind of, comprising: the specific antibody for enhancing the dyeing enhancement solution of dyeing effect and with fluorescent staining label;Wherein the specific antibody includes: ASGPR1 antibody, CD45 antibody and CPS1 antibody;The dyeing enhancement solution includes the surfactant that concentration is 0.001~1mg/mL.Kit of the invention can effectively be enriched with target cell, and confirm whether the target cell of enrichment derives from the early stage patient of liver cancer.Meanwhile the present invention passes through double tumor mark detections and increases nodule detection sensitivity and further guarantee the accuracy of detection by the detection of CEP8.It in addition, the present invention reinforces dyeing effect by dyeing enhancement solution, dye a variety of antibody with fluorescent staining label can to target cell, dyeing effect is more preferable, and fluorescence is stronger, and sharpness of border in conjunction with target cell. |
priorityDate | 2017-03-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 46.